About UBX domain-containing protein 11
UBX domain-containing protein 11 (UBXN11) is a protein
from Homo sapiens identified by UniProt accession
Q5T124, 520 residues long.
MolForge cross-references it against 0 known binders and
341 disease associations.
Target properties
| Protein name | UBX domain-containing protein 11 |
| UniProt accession | Q5T124 |
| Gene | UBXN11 |
| Organism | Homo sapiens |
| Length | 520 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (341)
Diseases linked to this target (Open Targets).
- eosinophil count · score 0.29
- monocyte count · score 0.28
- monocyte percentage of leukocytes · score 0.25
- glioblastoma multiforme · score 0.22
- platelet count · score 0.21
- brain measurement · score 0.16
- lymphocyte:monocyte ratio · score 0.15
- lymphocyte count · score 0.13
- eosinophil percentage of leukocytes · score 0.12
- PR interval · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5T124-F1 | alphafold | PREDICTED | 71.58 | — |
Amino-acid sequence (520 residues)
MSSPLASLSK TRKVPLPSEP MNPGRRGIRI YGDEDEVDML SDGCGSEEKI SVPSCYGGIG APVSRQVPAS HDSELMAFMT RKLWDLEQQV KAQTDEILSK DQKIAALEDL VQTLRPHPAE ATLQRQEELE TMCVQLQRQV REMERFLSDY GLQWVGEPMD QEDSESKTVS EHGERDWMTA KKFWKPGDSL APPEVDFDRL LASLQDLSEL VVEGDTQVTP VPGGARLRTL EPIPLKLYRN GIMMFDGPFQ PFYDPSTQRC LRDILDGFFP SELQRLYPNG VPFKVSDLRN QVYLEDGLDP FPGEGRVVGR QLMHKALDRV EEHPGSRMTA EKFLNRLPKF VIRQGEVIDI RGPIRDTLQN CCPLPARIQE IVVETPTLAA ERERSQESPN TPAPPLSMLR IKSENGEQAF LLMMQPDNTI GDVRALLAQA RVMDASAFEI FSTFPPTLYQ DDTLTLQAAG LVPKAALLLR ARRAPKSSLK FSPGPCPGPG PGPSPGPGPG PSPGPGPGPS PCPGPSPSPQ
Explore UBX domain-containing protein 11 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets